Efficacy and Safety of Imatinib in Scleroderma

Clinical trial NCT00479934 · COMPLETED

Trial details

NCT number: NCT00479934
Sponsor: University Hospital, Bordeaux
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Scleroderma, Localized Scleroderma, Systemic

Start date: 2007-12-01
Primary completion: 2010-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.